Who Won the U.S. Presidential Debate?

A rise in counterfeit versions of sought-after weight loss drug has led to a series of hospitalisations.

Around the globe, the growing class of weight loss drugs called GLP-1 agonists has been a game-changer. This includes the blockbuster drug semaglutide, better known by its brand names Ozempic and the more potent Wegovy. These have helped people lose weight, feel more confident and be healthier.

But a surge in demand and a high price tag have led to a rise in counterfeit versions of the drugs – causing hospitalisations around the world.

That includes Mike Benson of Chicago, who fell into a coma after taking a counterfeit version of Ozempic. Benson, who on the advice of counsel declined to comment, told a local TV station in January, “I don’t know that I’ve ever felt that way in my life. I had thought this could be the end.”

Michelle Sword, a mother of two living in Oxfordshire, England, had hypoglycemia and seizures, requiring her to be hospitalised.

• Read More